Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'

During Tuesday’s CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer emphasizing heightened threats following a recent breach at UnitedHealth.

Wells Fargo raised its price target on Salesforce Inc (NYSE:CRM) shares to $300 from $290 ahead of quarterly results but maintained a hold rating, signaling potential challenges. Cramer interpreted this as a “red flag,” cautioning investors about possible skepticism from analysts, which could impact sentiment post-earnings.

Why It Matters: In November 2023, Cramer predicted a “very good quarter” for cybersecurity firm Palo Alto Networks, indicating his long-standing faith in the sector, which further justifies his advice to go long on the company.

Earlier this month, Cramer warned of the potential impact of GLP-1s, a new class of weight loss and diabetes drugs, on food and beverage stocks, which might explain his reassurance about Eli Lilly’s performance.

Read Next: ‘Dogecoin Killer’ Shiba Inu Witnesses Massive 421.6B Token Move By Whale, Resulting In $6M+ Loss

Image Via Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.